Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be an effective
treatment for melanoma.
PURPOSE: This early phase I trial is studying how well riluzole works in treating patients
with stage III or stage IV melanoma that can be removed by surgery.
Phase:
Phase 1
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey